Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.9M Sell
142,021
-8,371
-6% -$1.86M 0.39% 60
2025
Q4
$34.4M Sell
150,392
-595
-0.4% -$136K 0.43% 52
2025
Q3
$35M Buy
150,987
+5,969
+4% +$1.22M 0.45% 48
2025
Q2
$26.9M Sell
145,018
-324
-0.2% -$60.2K 0.37% 59
2025
Q1
$30.5M Sell
145,342
-748
-0.5% -$145K 0.45% 51
2024
Q4
$26M Sell
146,090
-14,373
-9% -$2.64M 0.36% 67
2024
Q3
$31.7M Buy
160,463
+14,226
+10% +$2.66M 0.45% 47
2024
Q2
$25.1M Sell
146,237
-5,657
-4% -$937K 0.38% 57
2024
Q1
$27.7M Sell
151,894
-9,002
-6% -$1.55M 0.43% 52
2023
Q4
$24.9M Sell
160,896
-2,597
-2% -$379K 0.43% 53
2023
Q3
$24.4M Sell
163,493
-9,050
-5% -$1.33M 0.47% 50
2023
Q2
$23.2M Sell
172,543
-15,921
-8% -$2.33M 0.42% 58
2023
Q1
$30M Sell
188,464
-6,425
-3% -$982K 0.58% 34
2022
Q4
$31.5M Buy
194,889
+7,027
+4% +$1.08M 0.65% 29
2022
Q3
$25.2M Sell
187,862
-15,639
-8% -$2.24M 0.54% 38
2022
Q2
$31.2M Sell
203,501
-1,786
-0.9% -$273K 0.63% 32
2022
Q1
$33.3M Sell
205,287
-19,517
-9% -$2.84M 0.54% 37
2021
Q4
$30.4M Sell
224,804
-46,308
-17% -$5.47M 0.46% 48
2021
Q3
$29.2M Sell
271,112
-2,432
-0.9% -$278K 0.45% 49
2021
Q2
$30.8M Buy
273,544
+10,410
+4% +$1.17M 0.46% 46
2021
Q1
$28.5M Buy
263,134
+7,739
+3% +$828K 0.47% 42
2020
Q4
$27.4M Sell
255,395
-975
-0.4% -$93.7K 0.49% 38
2020
Q3
$22.5M Sell
256,370
-3,568
-1% -$336K 0.44% 46
2020
Q2
$25.5M Buy
259,938
+3,197
+1% +$281K 0.55% 31
2020
Q1
$19.6M Sell
256,741
-26,757
-9% -$2.28M 0.52% 32
2019
Q4
$25.1M Sell
283,498
-5,285
-2% -$439K 0.53% 38
2019
Q3
$21.9M Buy
288,783
+48,234
+20% +$3.31M 0.48% 44
2019
Q2
$17.5M Buy
240,549
+36,043
+18% +$2.83M 0.4% 62
2019
Q1
$16.5M Buy
204,506
+23,893
+13% +$1.95M 0.39% 62
2018
Q4
$16.7M Buy
180,613
+36,197
+25% +$3.18M 0.47% 44
2018
Q3
$13.7M Sell
144,416
-21,661
-13% -$2.05M 0.34% 64
2018
Q2
$15.4M Sell
166,077
-17,482
-10% -$1.71M 0.46% 47
2018
Q1
$17.4M Sell
183,559
-75,317
-29% -$8.27M 0.65% 30
2017
Q4
$25M Sell
258,876
-59,411
-19% -$5.6M 0.94% 18
2017
Q3
$28.3M Sell
318,287
-48,531
-13% -$3.69M 1.02% 13
2017
Q2
$26.6M Sell
366,818
-11,585
-3% -$779K 0.91% 13
2017
Q1
$24.7M Buy
378,403
+83,815
+28% +$5.27M 0.9% 13
2016
Q4
$18.4M Sell
294,588
-21,695
-7% -$1.32M 0.75% 23
2016
Q3
$19.9M Buy
316,283
+51,406
+19% +$3.33M 0.87% 16
2016
Q2
$16.4M Buy
264,877
+39,340
+17% +$2.4M 0.73% 19
2016
Q1
$12.9M Buy
225,537
+102,864
+84% +$5.73M 0.63% 27
2015
Q4
$7.27M Buy
122,673
+26,462
+28% +$1.52M 0.36% 60
2015
Q3
$5.24M Buy
96,211
+4,176
+5% +$272K 0.27% 76
2015
Q2
$6.18M Buy
92,035
+29,818
+48% +$1.95M 0.28% 70
2015
Q1
$3.64M Buy
62,217
+4,419
+8% +$267K 0.17% 138
2014
Q4
$3.78M Buy
57,798
+1,685
+3% +$106K 0.18% 134
2014
Q3
$3.24M Sell
56,113
-20,319
-27% -$1.13M 0.16% 158
2014
Q2
$4.31M Sell
76,432
-516
-0.7% -$27.1K 0.22% 105
2014
Q1
$3.96M Sell
76,948
-32,020
-29% -$1.62M 0.22% 109
2013
Q4
$5.75M Buy
108,968
+411
+0.4% +$20.2K 0.29% 52
2013
Q3
$4.86M Sell
108,557
-13,742
-11% -$609K 0.26% 66
2013
Q2
$5.06M Buy
+122,299
New +$5.35M 0.28% 62

Other funds holding ABBV

Stephens Inc's ABBV Position: Q1 2026 in Review

Stephens Inc reduced its AbbVie (ABBV) stake by 5.6% in Q1 2026, selling an estimated $1.86M and leaving 142,021 shares worth $30.9M. The position accounts for 0.39% of the portfolio, ranked #60.

Stephens Inc first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $35M in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Stephens Inc held 142,021 shares of AbbVie worth $30.9M as of Q1 2026.
  • Stephens Inc sold 8,371 AbbVie shares in Q1 2026, an estimated $1.86M.
  • AbbVie made up 0.39% of Stephens Inc's portfolio in Q1 2026, its #60 holding.
  • Stephens Inc first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • Stephens Inc's AbbVie position peaked at $35M in Q3 2025.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Stephens Inc's 13F filing for Q1 2026, filed 28 Apr 2026.